N/A N=39 Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Myocardial Infarction · Myocardial Ischemia
Primary: esCCO (Estimated Continuous Cardiac Output) Monitor — 5.6 liters/minute
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=133 Project to Improve Symptoms and Mood in People With Spinal Cord Injury
Major Depressive Disorder · Dysthymia · Spinal Cord Injuries
Primary: Hamilton Depression Rating Scale-17 — 19.5; 19.4; 9.5; 9.5 units on a scale — p=<.025
N/A N=42 Efficacy and Safety of Licefreee Spray Against Nix 1% Permethrin
Pediculosis Capitis
Primary: The Proportion Within Each Treatment Group of Subjects Who Have no Live Lice — 17; 9 participants
Phase 1 N=12 Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
Epilepsy
Primary: Cmax - Maximum Observed Plasma Drug Concentration — 22210; 16667; 12195; 685 ng/mL
Phase 4 N=63 Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia
Primary: International Prostate Symptom Score — 11.31 units on a scale
N/A N=250 Pharmacist-led Group Medical Visits to Help With Diabetes Management
Diabetes Mellitus · Cardiovascular Diseases
Primary: Hemoglobin A1c — 7.8; 8.1 percent Hemoglobin A1c
Phase 2 N=90 Ibuprofen Versus Acetaminophen vs Their Combination in the Relief of Musculoskeletal Pain in the Emergency Setting
Pain
Primary: Pain Severity — 39; 43; 42 mm
Phase 4 N=21 Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
Hypertension
Primary: Forearm Blood Flow — 96; 105 ml/min
Phase 2 N=306 A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Colorectal Cancer
Primary: Percentage of Participants With Disease Progression or Death — 86.14; 90.20; 88.35 percentage of participants
Phase 3 N=180 Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India
Bacterial Meningitis
Primary: Percentages of Subjects With Human Serum Bactericidal Assay (hSBA) Seroresponse Against N.Meningitidis Serogroup A. — 75; 76; 66; 72 Percentages of subjects
Phase 3 N=305 Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery
Diabetes
Primary: Number of Subjects That Were Diagnosed for Peri-operative Complications — 58; 70 participants
Phase 2 N=90 A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder
Intermittent Explosive Disorder
Primary: Overt Aggression Scale-Modified for Outpatient Use (OAS-M) — 7.86; 15.73; 8.88 units on a scale — p=0.622
Phase 4 N=150 Diabetes in the Elderly: Prospective Study
Diabetes · Hyperglycemia
Primary: Percent of Participants With a Mean Blood Glucose Concentration of Less Than 70 mg/dL — 28; 31 percentage of participants
N/A N=497 Understanding Quality and Equity in Wheelchairs for Veterans
Spinal Cord Injuries · Amputees
Primary: Quality of Life Assessed With the Veterans RAND 12 Item Health Survey (VR-12) — 44.7; 43.6 units on a scale
Phase 1 N=13 The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin
Epilepsy
Primary: Cmax - Maximum Steady-state Plasma Concentration — 27571; 2,350; 1,909 ng/mL